Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Two novel radioligands, N,N-dimethyl-2-(2-amino-4-methoxyphenylthio) b enzylamine (DAPP) and (N,N-dimethyl-2-(2-amino-4-cyanophenylthio) benzylamine (D ASB), were radiolabeled with carbon-11 and evaluated as in vivo probes of the serotonin transporter (SERT) using positron emission tomography (PET). Both compounds are highly selective, with nanomolar affinity for the serotonin transporter and micromolar affinity for the dopamine and norepinephrine transporters. Six volunteers were imaged twice, once with each of the two radioligands. Both ligands displayed very good brain penetration and selective retention in regions rich in serotonin reuptake sites. Both had similar brain uptake and kinetics, but the cyano analogue, [11C]DASB, had a slightly higher brain penetration in all subjects. Plasma analysis revealed that both radiotracers were rapidly metabolized to give mainly hydrophilic species as determined by reverse-phase high-performance liquid chromatography. Inhibition of specific binding to the SERT was demonstrated in three additional subjects imaged with [11C]DASB following an oral dose of the selective serotonin reuptake blocker citalopram. These preliminary studies indicate that both these substituted phenylthiobenzylamines have highly suitable characteristics for probing the serotonin reuptake system with PET in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a total of 16 articles (reporting on 17 unique studies) were included [17–19, 28–40].”
From The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review (2022) · cites this paper as [34]
In the citing paper
“One study reported overall alcohol consumption during the study period [35], and seven studies controlled for present or past alcohol problems or abuse [17, 28, 30, 33, 34, 39, 40].”
From The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review (2022) · cites this paper as [34]
Citations
Cites
Wilson, A. A., Ginovart, N., Schmidt, M., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationRadiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent method
Wilson, A. A., Garcia, A., Jin, L., & Houle, S. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00132-3 · Cited by 201
Self-citationSzabo, Z., Kao, P. F., Scheffel, U., Suehiro, M., Mathews, W. B., Ravert, H. T., Musachio, J. L., Marenco, S., Kim, S. E., Ricaurte, G. A., et al. (1995) · Synapse · doi:10.1002/syn.890200107 · Cited by 170
Laruelle, M., Vanisberg, M.-A., & Maloteaux, J.-M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90198-9 · Cited by 166
High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue
Ba¨ckstro¨m, I., Bergstro¨m, M., & Marcusson, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90511-8 · Cited by 162
Wilson, A. A., & Houle, S. (1999) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(19991230)42:13<1277::aid-jlcr284>3.0.co;2-q · Cited by 71
Self-citationSmith, D. F. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00042-5 · Cited by 33
Acton, P. D., Kung, M., Mu, M., Plöessl, K., Hou, C., Siciliano, M., Oya, S., & Kung, H. F. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050459 · Cited by 33
Cited by
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Ichise, M., Liow, J.-S., Lu, J.-Q., Takano, A., Model, K., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 650
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
“In the second study, PET measurements were taken after 13 days of multiple dosing of vortioxetine in 35 young healthy Caucasian or Japanese subjects with the selective SERT ligand [11C]-DASB (3-amino-4-(2dimethylaminomethylphenylsulfanyl)-benzonitrile) (Houle et al., 2000).”
MethodMeyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517
“With [11C]DASB PET, 5-HTT binding potential values are detectable in the frontal cortex and are reasonably high in the basal ganglia and thalamus, even without arterial sampling (11, 12).”
BackgroundMethodSelf-citationSerotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 448
Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V., Hussey, D., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 340
Self-citationFatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 333
Seasonal Variation in Human Brain Serotonin Transporter Binding
Praschak-Rieder, N., Willeit, M., Wilson, A. A., Houle, S., & Meyer, J. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1072 · Cited by 278
“Synthesis of [(11)C]DASB measurement of serotonin transporter binding potential with [(11)C]DASB PET scanner and methods reported in this study are the same as those used in previous studies.(26,30-35) The ROIs were delineated using an automated software program,(32) as described previously.”
MethodSelf-citationMeyer, J. H. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0709 · Cited by 272
“The radiotracer [11C] 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile (DASB) was a major advance because of its selectivity, reversibility, greater specific binding relative to free and nonspecific binding and reliability.(20,21,26,27,34,35,40,43,47) This radiotracer was found to be 3 orders of magnitude…”
Self-citationMeyer, J. H., Houle, S., Sagrati, S., Carella, A., Hussey, D. F., Ginovart, N., Goulding, V., Kennedy, J., & Wilson, A. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1271 · Cited by 266
“As a result, with [(11)C]DASB PET, 5-HTT BP values are quantifiable in prefrontal cortex and reasonably high in the basal ganglia and thalamus, even without arterial sampling.(22,23) Furthermore, the 5-HTT BP found with [(11)C]DASB PET is reliable for most brain regions under test-retest conditions.”
ResultSelf-citationNormative database of the serotonergic system in healthy subjects using multi-tracer PET
Savli, M., Bauer, A., Mitterhauser, M., Ding, Y.-S., Hahn, A., Kroll, T., Neumeister, A., Haeusler, D., Ungersboeck, J., Henry, S., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.001 · Cited by 251
“The most promising PET ligands applied in the studies involving 5‐HTT are [11C]DASB (Houle et al., 2000) and [11C]MADAM (Lundberg et al., 2005).”
MethodMurphy, D. L., Fox, M. A., Timpano, K. R., Moya, P. R., Ren-Patterson, R., Andrews, A. M., Holmes, A., Lesch, K.-P., & Wendland, J. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.034 · Cited by 235
“In fact, more selective SERT ligands have become available recently for human PET studies including McN 5652 ([+]-6β-(4-methylthiophenyl)-1, 2, 3, 5, 6α, 10βhexahydropyrrolo[2,1-a]isoquinoline), and a group of diarylsulfides, particularly DASB (3amino-4[2-(dimethyl-aminomethylphenylthio)] benzonitrile) and AFM (2-[2-(…”
BackgroundInfluentialLaruelle, M. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.009 · Cited by 228
Cannon, D. M., Ichise, M., Rollis, D., Klaver, J. M., Gandhi, S. K., Charney, D. S., Manji, H. K., & Drevets, W. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.016 · Cited by 219
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D., & Houle, S. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00010 · Cited by 209
“As previously described (Houle et al., 2000), the regional distribution of [ 11 C]-DASB uptake was concordant with the known densities of SERT sites in the brain.”
Self-citationZhang, L., Villalobos, A., Beck, E. M., Bocan, T., Chappie, T. A., Chen, L., Grimwood, S., Heck, S. D., Helal, C. J., Hou, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400312y · Cited by 203
McCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., Dannals, R. F., & Ricaurte, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300736 · Cited by 204
“Recent studies in baboons (Szabo et al, 2002) and humans (Frankle et al, 2004; Houle et al, 2000; Meyer et al, 2001; Wilson et al, 2000) have demonstrated the suitability of a new SERT ligand, [11C]DASB, for studying serotonin neurons in the living brain.”
BackgroundPraschak-Rieder, N., Kennedy, J., Wilson, A. A., Hussey, D., Boovariwala, A., Willeit, M., Ginovart, N., Tharmalingam, S., Masellis, M., Houle, S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.022 · Cited by 203
Self-citationCannon, D. M., Ichise, M., Fromm, S. J., Nugent, A. C., Rollis, D., Gandhi, S. K., Klaver, J. M., Charney, D. S., Manji, H. K., & Drevets, W. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.005 · Cited by 197
Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease
Guttman, M., Boileau, I., Warsh, J., Saint‐Cyr, J. A., Ginovart, N., McCluskey, T., Houle, S., Wilson, A., Mundo, E., Rusjan, P., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01727.x · Cited by 187
“by PET imaging, levels of SERT binding in brain of non-depressed, non-demented patients with PD using a second generation probe [(11)C]-3-amino4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile ([(11)C]-DASB) having high specificity and sensitivity for SERT [5].”
MethodSelf-citationRegional distribution of serotonin transporter protein in postmortem human brain
Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.10.001 · Cited by 179
Self-citationBoileau, I., Warsh, J. J., Guttman, M., Saint‐Cyr, J. A., McCluskey, T., Rusjan, P., Houle, S., Wilson, A. A., Meyer, J. H., & Kish, S. J. (2008) · Movement Disorders · doi:10.1002/mds.22212 · Cited by 171
Self-citationWilson, A. A., Ginovart, N., Hussey, D. F., Meyer, J., & Houle, S. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00316-5 · Cited by 157
Self-citation5‐HT radioligands for human brain imaging with PET and SPECT
Paterson, L. M., Kornum, B. R., Nutt, D. J., Pike, V. W., & Knudsen, G. M. (2011) · Medicinal Research Reviews · doi:10.1002/med.20245 · Cited by 159
“PET studies of [(11)C]DASB in humans showed that the uptake distribution matched that expected for SERT and binding kinetics could be quantified with reference tissue models.(367,372) It was quickly realized that [(11)C]DASB was a superior PET ligand to [(11)C](1)McN5652, both in baboons(373) and in humans(354) but al…”
Frankle, W. G., Huang, Y. H., Hwang, D. R., Talbot, P. S., Slifstein, M., Heertum, R. V., Abi‐Dargham, A., & Laruelle, M. A. (2004) · PubMed · Cited by 146
Huang, Y., Hwang, D.-R., Narendran, R., Sudo, Y., Chatterjee, R., Bae, S.-A., Mawlawi, O., Kegeles, L. S., Wilson, A. A., Kung, H. F., et al. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200211000-00011 · Cited by 147
“Furthermore, two of these new compounds, [11C]DASB and [11C]DAPP, were evaluated in humans (Houle et al., 2000).”
BackgroundInfluentialSelf-citationThe personality trait openness is related to cerebral 5-HTT levels
Kalbitzer, J., Frøkjær, V. G., Erritzøe, D., Svarer, C., Cumming, P. D., Nielsen, F. Å., Hashemi, S. H., Baaré, W. F. C., Madsen, J., Hasselbalch, S. G., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.001 · Cited by 153
Szabó, Z. R., McCann, U. D., Wilson, A. A., Scheffel, U., Owonikoko, T. K., Mathews, W. B., Ravert, H. T., Hilton, J., Dannals, R. F., & Ricaurte, G. A. (2002) · PubMed · Cited by 134
Self-citationHow strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Kish, S. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00708-0 · Cited by 147
“(For comparison, see a much tighter distribution of SERT brain levels in normal human subjects using a radioligand with a higher specific/nonspecific binding and in which the nonspecific binding was calculated using a more conventional procedure (Houle et al., 2000)).”
MethodReimold, M., Batra, A., Knobel, A., Smolka, M. N., Zimmer, A., Mann, K. F., Solbach, C., Reischl, G., Schwärzler, F., Gründer, G., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002149 · Cited by 146
Spared Caudal Brainstem SERT Binding in Early Parkinson's Disease
Albin, R. L., Koeppe, R. A., Bohnen, N. I., Wernette, K., Kilbourn, M. A., & Frey, K. A. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600599 · Cited by 132
“[ 11 C]-3-Amino-4-(2-dimethylaminomethyl- phenylsulfaryl)-benzonitrile (DASB) is a PET ligand with high SERT sensitivity and specificity (Houle et al, 2000; Frankle et al, 2004).”
BackgroundSerotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study
Frick, A., Åhs, F., Engman, J., Jonasson, M., Alaie, I., Björkstrand, J., Frans, Ö., Faria, V., Linnman, C., Appel, L., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0125 · Cited by 128
Suhara, T., Takano, A., Sudo, Y., Ichimiya, T., Inoue, M., Yasuno, F., Ikoma, Y., & Okubo, Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.386 · Cited by 126
Reimold, M., Smolka, M. N., Schumann, G., Zimmer, A., Wrase, J., Mann, K. F., Hu, X., Goldman, D. A., Reischl, G., Solbach, C., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-006-0609-0 · Cited by 139
“Unlike b-CIT, DASB is highly selective (Houle et al., 2000) and there is in vitro (Hummerich et al., 2004) and in vivo (Talbot et al., 2005; Praschak-Rieder et al., 2005) evidence that DASB is not being displaced by endogenous serotonin.”
BackgroundLameka, K., Farwell, M. D., & Ichise, M. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00011-8 · Cited by 185
Parsey, R. V., KENT, J. M., Oquendo, M. A., Richards, M., Pratap, M., Cooper, T. B., Arango, V., & Mann, J. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.010 · Cited by 120
Pagano, G., Niccolini, F., Fusar‐Poli, P., & Politis, M. (2016) · Annals of Neurology · doi:10.1002/ana.24859 · Cited by 117
“Several PET ligands have been developed for the evaluation of serotonergic receptors and serotonin transporter (SERT).(9) [(11)C]-3-amino-4-(2dimethylaminomethylphenylsulfaryl)-benzonitrile ([(11)C]DASB) is a second-generation PET ligand with high selectivity for the SERT,(9) which is superior compared to first-genera…”
BackgroundSerotonin and molecular neuroimaging in humans using PET
Saulin, A., Savli, M., & Lanzenberger, R. (2012) · Amino Acids · doi:10.1007/s00726-011-1078-9 · Cited by 113
Positron emission tomography: imaging and quantification of neurotransporter availability
Laruelle, M. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00085-3 · Cited by 114
Molecular targeting with radionuclides: state of the science.
Britz-Cunningham, S. H., & Adelstein, S. J. (2003) · PubMed · Cited by 114
Andersen, J., Kristensen, A. S., Bang‐Andersen, B., & Strømgaard, K. (2009) · Chemical Communications · doi:10.1039/b903035m · Cited by 120
Kalbitzer, J., Erritzøe, D., Holst, K. K., Nielsen, F. Å., Marner, L., Lehel, S., Arentzen, T., Jernigan, T. L., & Knudsen, G. M. (2008) · Nature Precedings · doi:10.1016/j.biopsych.2009.11.027 · Cited by 114
A dose-finding study of duloxetine based on serotonin transporter occupancy
Takano, A., Suzuki, K., Kosaka, J., Ota, M., Nozaki, S., Ikoma, Y., Tanada, S., & Suhara, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0304-0 · Cited by 110
“In this study, the thalamus was used to measure 5-HTT occupancy because it has the highest specific binding in the brain (Houle et al. 2000).”
MethodSerotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
Politis, M., & Loane, C. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/172893 · Cited by 109
Cerebral serotonin transporter binding is inversely related to body mass index
Erritzøe, D., Frøkjær, V. G., Haahr, M. E., Kalbitzer, J., Svarer, C., Holst, K. K., Hansen, D. L., Jernigan, T. L., Lehel, S., & Knudsen, G. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.086 · Cited by 107
“As a robust measure of cerebral SERT binding, a high-binding subcortical region consisting of 3 paired regions with high, homogenous binding (Houle et al., 2000a,b) was computed as the volumeweighted average of binding in caudate, putamen and thalamus.”
MethodVicario, C. M., Rafal, R. D., Martino, D., & Avenanti, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.008 · Cited by 103
“Moreover, a growing line of research suggests that PD is a diffuse pathology, also involving the 5-HT system (Houle et al., 2000; Bédard et al., 2011).”
BackgroundWassink, T. H., Hazlett, H. C., Epping, E. A., Arndt, S. V., Dager, S. R., Schellenberg, G. D., Dawson, G., & Piven, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.709 · Cited by 114
Alterations of Serotonin Transmission in Schizophrenia
Abi‐Dargham, A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78005-9 · Cited by 120
Ding, Y., Naganawa, M., Gallezot, J., Nabulsi, N., Lin, S.-F., Ropchan, J. R., Weinzimmer, D. P., McCarthy, T. J., Carson, R. E., Huang, Y. H., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.001 · Cited by 103
Effects of Tryptophan Depletion on the Serotonin Transporter in Healthy Humans
Praschak-Rieder, N., Wilson, A. A., Hussey, D., Carella, A., Wei, C. W., Ginovart, N., Schwarz, M., Zach, J., Houle, S., & Meyer, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.038 · Cited by 92
Self-citationBrain-Mapping Techniques for Evaluating Poststroke Recovery and Rehabilitation: A Review
Eliassen, J. C., Boespflug, E. L., Lamy, M., Allendorfer, J. B., Chu, W., & Szaflarski, J. P. (2008) · Topics in Stroke Rehabilitation · doi:10.1310/tsr1505-427 · Cited by 97
“5HT transporter, these include (123)I-ADAM,(106) (11)CMADAM,(107) and (11)C-DASB.(108) For the dopamine transporter, examples include (99)Tc-TRODAT,(109) (123)I -bCIT,(110) and (18)F FPCIT.”
BackgroundQuantitative imaging of protein targets in the human brain with PET
Gunn, R. N., Slifstein, M., Searle, G. E., & Price, J. C. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/22/r363 · Cited by 99
Willeit, M., & Praschak-Rieder, N. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.030 · Cited by 87
“…with two ligands, [11C]-(+)-6beta-(4-Methylthiophenyl)-1,2,3,5,6alpha,10beta-hexahydropyrrolo[2,1-a]isoquinoline ([11C]McN 5652; Suehiro et al., 1993) and [11C]-3-amino-4-(2dimethylaminomethylphenylthio)benzonitrile ([11C]DASB; Wilson et al., 2000; Houle et al., 2000; Wilson and Houle, 1999).”
BackgroundRelationship Between Neuroticism Personality Trait and Serotonin Transporter Binding
Takano, A., Arakawa, R., Hayashi, M., Takahashi, H., Ito, H., & Suhara, T. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.007 · Cited by 90
Kim, J. S., Ichise, M., Sangare, J., & Innis, R. B. (2006) · PubMed · Cited by 79
Application of cross-species PET imaging to assess neurotransmitter release in brain
Finnema, S. J., Scheinin, M., Shahid, M., Lehto, J., Borroni, E., Bang-Andersen, B., Sallinen, J., Wong, E., Farde, L., Halldin, C., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3938-6 · Cited by 78
“Another approach has made use of radioligands targeting the SERT, e.g., [11C]DASB (Houle et al. 2000) and [11C]MADAM (Halldin et al. 2005), which were originally used for the determination of SERT occupancy by inhibitors of serotonin reuptake (tricyclic antidepressants and SSRI drugs).”
MethodReimold, M., Smolka, M. N., Zimmer, A., Batra, A., Knobel, A., Solbach, C., Mundt, A. P., Smoltczyk, H., Goldman, D. A., Mann, K. F., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0785-6 · Cited by 86
Talbot, P. S., Frankle, W. G., Hwang, D., Huang, Y. H., Suckow, R. F., Slifstein, M., Abi‐Dargham, A., & Laruelle, M. A. (2004) · Synapse · doi:10.1002/syn.20105 · Cited by 85
Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., Månsson, K. N. T., Wahlstedt, K., Jonasson, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0618-7 · Cited by 81
Fluoxetine Administered to Juvenile Monkeys: Effects on the Serotonin Transporter and Behavior
Shrestha, S., Nelson, E. E., Liow, J., Gladding, R. L., Lyoo, C. H., Noble, P. L., Morse, C. L., Henter, I. D., Kruger, J., Zhang, B., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020183 · Cited by 80
“) using two PET radioligands: |"C|DASB to label SERT and |"CJ(fi)-RWAY to label 5-HTiA receptors (24, 25).”
MethodCentral serotonin transporter levels are associated with stress hormone response and anxiety
Reimold, M., Knobel, A., Rapp, M. A., Batra, A., Wiedemann, K., Ströhle, A., Zimmer, A., Schönknecht, P., Smolka, M. N., Weinberger, D. R., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1903-y · Cited by 72
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D. F., & Houle, S. (2002) · Synapse · doi:10.1002/syn.10155 · Cited by 82
“…of SERT in the brain and that, due to the favorable binding kinetics of [11C]-DASB, reliable estimates of SERT sites densities can be obtained using simplified methods of quantification which do not require arterial sampling or plasma metabolite analysis (Houle et al., 2000; Ginovart et al., 2001).”
Self-citationRadiopharmaceutical chemistry for positron emission tomography
Elsinga, P. H. (2002) · Methods · doi:10.1016/s1046-2023(02)00076-2 · Cited by 71
Sørensen, A., Ruhé, H. G., & Munkholm, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01285-w · Cited by 65
Voineskos, A. N., Wilson, A. A., Boovariwala, A., Sagrati, S., Houle, S., Rusjan, P., Sokolov, S. T. H., Spencer, E. P., Ginovart, N., & Meyer, J. H. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0806-z · Cited by 81
Self-citationOgden, R. T., Ojha, A., Erlandsson, K., Oquendo, M. A., Mann, J. J., & Parsey, R. V. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600329 · Cited by 67
“& 2007 ISCBFM All rights reserved 0271-678X/07 $30.00 www.jcbfm.com (Frankle et al, 2004; Ginovart et al, 2001; Houle et al, 2000; Wilson et al, 2002, 2000).”
Influential[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET
Halldin, C., Lundberg, J., Sóvágó, J., Gulyás, B. Z., Guilloteau, D., Vercouillie, J., Emond, P., Chalon, S., Tarkiainen, J., Hiltunen, J. O., et al. (2005) · Synapse · doi:10.1002/syn.20189 · Cited by 68
“Another 11C-labeled analog of ADAM, the cyanosubstituted phenylthio-benzylamine derivative DASB, has been demonstrated to have promising characteristics for PET examination of 5-HTT in the human brain (Ginovart et al., 2001; Houle et al., 2000; Meyer et al., 2001).”
Tarkiainen, J., Vercouillie, J., Guilloteau, D., Gulyás, B. Z., Sóvágó, J., Cselényi, Z., Emond, P., Chalon, S., Sandell, J., Hiltunen, J. O., et al. (2001) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580440167 · Cited by 68
Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders
Bohnen, N. I., & Frey, K. A. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0083-6 · Cited by 70
“The more recent introduction of [C-11]DASB affords more robust kinetic analysis options and a much higher saturableto-nonsaturable brain uptake, leading to precise estimates of SERT in brain stem and forebrain regions [103].”
BackgroundDing, Y., Lin, K., Logan, J., Benveniste, H., & Carter, P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03202.x · Cited by 67
“However, our intention to develop tomoxetine as a selective NET tracer for positron emission tomography (PET) studies was discouraged by our characterization studies (Ding et al., unpublished results) in baboon using [11C] DASB, a selective SERT ligand (Houle et al. 2000).”
MethodRadiopharmaceuticals for single-photon emission computed tomography brain imaging
Kung, H. F., Kung, M., & Choi, S. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127296 · Cited by 69
Shao, X., Hoareau, R., Runkle, A. C., Tluczek, L. J. M., Hockley, B. G., Henderson, B. D., & Scott, P. J. H. (2011) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1937 · Cited by 79
Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders
Hesse, S., Barthel, H., SCHWARZ, J., Sabri, O., & Müller, U. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.004 · Cited by 66
Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants
Brühl, A. B., Kaffenberger, T., & Herwig, U. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.159 · Cited by 73
“…and thalamic regions fit with the anatomical and neurochemical distribution of noradrenergic innervation in the brain with a lack of noradrenergic innervation in the striatum including the caudate (eg, Kung et al, 2004; Wilson et al, 2003; Schou et al, 2005; Varnas et al, 2004; Houle et al, 2000).”
Tarkiainen, J., Vercouillie, J., Emond, P., Sandell, J., Hiltunen, J. O., FRANGIN, Y., Guilloteau, D., & Halldin, C. (2001) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.523 · Cited by 64
Huang, Y. H., Bae, S.-A., Zhu, Z., Guo, N., Roth, B. L., & Laruelle, M. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0400808 · Cited by 63
Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys
Banks, M. L., Czoty, P. W., Gage, H. D., Bounds, M. C., Garg, P., Garg, S., & Nader, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301420 · Cited by 60
“[11C]DASB has a higher affinity for SERT compared to DAT and NET and appears to be a more selective and improved radioligand for the SERT compared to [11C]McN5652 (Houle et al, 2000; Szabo et al, 2002).”
ResultHerold, N., Uebelhack, K., Franke, L., Amthauer, H., Luedemann, L., Bruhn, H., Felix, R., Uebelhack, R., & Plotkin, M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0429-7 · Cited by 61
“Therefore, new tracers for PET [11C]-ADAM, [11C]-DASB, [11C]DAPA and [11C]-AFM, have been recently developed (Houle et al., 2000; Huang et al., 2002).”
MethodFrankle, W. G., Narendran, R., Huang, Y. H., Hwang, D., Lombardo, I., Cangiano, C., Gil, R. B., Laruelle, M. A., & Abi‐Dargham, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.028 · Cited by 60
Urban, N., Girgis, R. R., Talbot, P. S., Kegeles, L. S., Xu, X., Frankle, W. G., Hart, C. L., Slifstein, M., Abi‐Dargham, A., & Laruelle, M. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.332 · Cited by 63
Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor
Parker, C. A., Gunn, R. N., Rabiner, E. A., Slifstein, M., Comley, R. A., Salinas, C. A., Johnson, C. N., Jakobsen, S., Houle, S., Laruelle, M. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093419 · Cited by 59
“Of these, the serotonergic system has received much attention with the development of PET radioligands for the 5-hydroxytryptamine (5-HT) 1A (1), 5-HT1B (2), 5-HT2A (3), and 5-HT4 receptors (4), along with the 5-HT transporter (5).”
BackgroundSelf-citationNeuroreceptor imaging in psychiatric disorders
Frankle, W. G., & Laruelle, M. A. (2002) · Annals of Nuclear Medicine · doi:10.1007/bf02988639 · Cited by 77
Pavese, N., Simpson, B. S., Metta, V., Ramlackhansingh, A. F., Chaudhuri, К. R., & Brooks, D. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.034 · Cited by 57
Visser, A. K. D., van Waarde, A., Willemsen, A. T. M., Bosker, F. J., Luiten, P. G. M., den Boer, J. A., Kema, I. P., & Dierckx, R. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1663-2 · Cited by 58
“In Table 1, the most often used radiotracers to measure aspects of the serotonin system are listed [5–25].”
MethodBallanger, B., Beaudoin‐Gobert, M., Neumane, S., Epinat‐Duclos, J., Météreau, É., Duperrier, S., Broussolle, E., Thobois, S., Bonnefoi, F., Tourvielle, C., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2010-15.2016 · Cited by 51
Milak, M. S., Ogden, R. T., Vinocur, D. N., Heertum, R. L. V., Cooper, T. B., Mann, J. J., & Parsey, R. V. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.026 · Cited by 54
Chou, Y. H., Wang, S., Lin, C., Mao, W., Lee, S., & Liao, M. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00800.x · Cited by 50
Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg, A. B., Plößl, K., Mozley, P. D., Stubbs, J. B., Wintering, N., Udeshi, M., Alavi, A. A., Kauppinen, T., & Kung, H. F. (2004) · PubMed · Cited by 48
Prediction of Selective Serotonin Reuptake Inhibitor Response Using Diffusion-Weighted MRI
DeLorenzo, C., Delaparte, L., Thapa-Chhetry, B., Miller, J. M., Mann, J. J., & Parsey, R. V. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00005 · Cited by 47
“Serotonin transporter binding was assessed using the PET tracer [11C]DASB (Houle et al., 2000) and the outcome measure V T/fp, where V T is the volume of distribution (or ratio of the concentration of the ligand in the region to that in the plasma at equilibrium) and fp is the free fraction (Innis…”
BackgroundMethodInfluentialGirgis, R. R., Slifstein, M., Xu, X., Frankle, W. G., Anagnostou, E. A., Wasserman, S., Pepa, L., Kolevzon, A., Abi‐Dargham, A., Laruelle, M. A., et al. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.007 · Cited by 48
Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography
Ma, K.-H., Huang, W.-S., Kuo, Y.-Y., Peng, C.-J., Liou, N.-H., Liu, R.-S., Hwang, J.-J., Liu, J.-C., Chen, H.-J., & Shiue, C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.060 · Cited by 44
“Its analog, [ 11 C]N,N-dimethyl-2-(2- amino-4-cyanophenylthio)benzylamine ([ 11 C]DASB), was subsequently synthesized (Wilson et al., 2000) and shown to be a potential radioligand for PET studies of SERT in humans (Houle et al., 2000).”
Nogami, T., Takano, H., Arakawa, R., Ichimiya, T., Fujiwara, H., Kimura, Y., Kodaka, F., Sasaki, T., Takahata, K., Suzuki, M., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001009 · Cited by 53
“A previous report suggested that the thalamus has the highest specific binding for 5-HTT in the brain (Houle et al. 2000).”
BackgroundOya, S., Choi, S., Coenen, H. H., & Kung, H. F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020167y · Cited by 46
Radiotracers for positron emission tomography imaging
Fowler, J. S., Ding, Y., & Volkow, N. D. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127297 · Cited by 44
Mehta, M. A., & Hawkins, P. C. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00068-1 · Cited by 42
Applying Neuroimaging Ligands to Study Major Depressive Disorder
Meyer, J. H. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.007 · Cited by 43
Self-citationLight therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex
Harrison, S. J., Tyrer, A. E., Levitan, R. D., Xu, X., Houle, S., Wilson, A. A., Nóbrega, J. N., Rusjan, P., & Meyer, J. H. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12424 · Cited by 42
Self-citationLaje, G., Cannon, D. M., Allen, A. S., Klaver, J. M., Peck, S. A., Liu, X., Manji, H. K., Drevets, W. C., & McMahon, F. J. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991027 · Cited by 47
“This radioligand has shown relatively greater specific :non-specific binding ratios in vivo than previously available 5-HTT radioligands (Ginovart et al. 2001 ; Houle et al. 2000 ; Huang et al. 2002 ; Wilson et al. 2002).”
BackgroundMethodHuang, Y. H., Hwang, D., Bae, S., Sudo, Y., Guo, N., Zhu, Z., Narendran, R., & Laruelle, M. A. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.11.008 · Cited by 40
Metadata
- Authors
- Houle, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Houle, S.
- Venue
- European Journal of Nuclear Medicine
- Published
- 2000-09-23
- Volume
- 27
- Issue
- 11
- Pages
- 1719-1722
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2169396775
- Cited by
- 276
- References
- 8
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 14 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 13 · 2013: 7 · 2012: 11
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- serotonin transporter, [11C]DASB, serotonin uptake, neuroimaging, radiotracer metabolism, citalopram, dopamine transporter, norepinephrine transporter, brain penetration
- MeSH terms
- Adult, Benzylamines, Carbon Radioisotopes, Carrier Proteins, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Tomography, Emission-Computed, Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.